Andreas Hotter
18Patents
2h-index
33Co-inventors
50Inventor score
Filing activity: Nov 12, 2008 → Nov 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8785455B2 | Polymorph of linagliptin benzoate | Chemistry; Metallurgy | 46 | Active |
| US8513224B2 | Crystalline form C of tigecycline dihydrochloride and methods for its preparation | Emerging Cross-Sectional Technologies | 2 | Active |
| US9586369B2 | Method for coating objects, in particular such objects that have been manufactured by a generative manufacturing method | Performing Operations; Transporting | 2 | Active |
| US9499504B2 | Crystalline form of vortioxetine hydrobromide | Human Necessities | 1 | Active |
| US8435998B2 | Crystalline form of posaconazole | Chemistry; Metallurgy | 1 | Active |
| US9732053B2 | 1-[2-(2,4-dimethylphenylsulfanyl) phenyl]piperazine acetate in crystalline form | Chemistry; Metallurgy | 1 | Active |
| US10265326B2 | Form C of avibactam sodium | Chemistry; Metallurgy | 1 | Active |
| US10189860B2 | Hydrates of dolutegravir sodium | Human Necessities | 0 | Active |
| US9534004B2 | Crystalline forms of ceftaroline fosamil | Chemistry; Metallurgy | 0 | Active |
| US11732133B2 | Process for producing a three-dimensional object | Chemistry; Metallurgy | 0 | Active |
| US9867829B2 | Stable pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof | Performing Operations; Transporting | 0 | Active |
| US8946441B2 | Polymorphs of an active pharmaceutical ingredient | Human Necessities | 0 | Active |
| US8252946B2 | Crystalline forms of tigecycline hydrochloride | Chemistry; Metallurgy | 0 | Active |
| US9670188B2 | Process for the preparation of crystalline form IV of posaconazole | Human Necessities | 0 | Active |
| US9062031B2 | Method of preparing polymorphic pure form A of bazedoxifene acetate | Human Necessities | 0 | Active |
| US8563555B2 | Pharmaceutical compositions containing a crystalline form of posaconazole | Emerging Cross-Sectional Technologies | 0 | Active |
| US12098297B2 | Polymer-based build material for selective sintering | Emerging Cross-Sectional Technologies | 0 | Active |
| US10323056B2 | Crystalline hydrates of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.